0001104659-22-110922.txt : 20221024 0001104659-22-110922.hdr.sgml : 20221024 20221024160932 ACCESSION NUMBER: 0001104659-22-110922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221020 FILED AS OF DATE: 20221024 DATE AS OF CHANGE: 20221024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kapur Anil CENTRAL INDEX KEY: 0001730703 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35403 FILM NUMBER: 221326164 MAIL ADDRESS: STREET 1: 275 MADISON AVE STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verastem, Inc. CENTRAL INDEX KEY: 0001526119 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273269467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: (781) 292-4200 MAIL ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 4 1 tm2228716-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-10-20 0 0001526119 Verastem, Inc. VSTM 0001730703 Kapur Anil C/O VERASTEM, INC., 117 KENDRICK ST., SUITE 500 NEEDHAM MA 02494 1 0 0 0 Stock Option (right to buy) 0.30 2022-10-20 4 A 0 163185 0 A 2032-10-20 Common Stock 163185 163185 D -125,000 of the stock options vest in twelve equal quarterly installments beginning each three successive month period following October 20, 2022 (the "Option Grant Date") until the third anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest). 38,185 of the stock options vest in eight equal month installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) beginning on the on the last day of each month over a period from October, 2022 to May, 2023. The options vest provided the Reporting Person continues to serve as a director of the Issuer on each such vesting date. /s/ Robert E. Gagnon, Attorney-in-Factor 2022-10-24